BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice. ✅
Go to Publication ✅
Journal of clinical biochemistry and nutrition (J Clin Biochem Nutr ) Vol: 65 Issue 1 Pages: 34-46 Pub: 2019 Jul Epub: 2019 Apr 6 Authors Ushiroda C , Naito Y , Takagi T , Uchiyama K , Mizushima K , Higashimura Y , Yasukawa Z , Okubo T , Inoue R , Honda A , Matsuzaki Y , Itoh Y , |
|
|
Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: Issue Pages: Pub: 2024 Apr 12 Epub: 2024 Apr 12 Authors Zuo G , Chen M , Zuo Y , Liu F , Yang Y , Li J , Zhou X , Li M , Huang JA , Liu Z , Lin Y , |
|
|
Epigallocatechin gallate alleviates osteoporosis by regulating the gut microbiota and serum metabolites in rats. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 23 Pages: 10564-10580 Pub: 2023 Nov 27 Epub: 2023 Nov 27 Authors Han X , Fu Y , Wang K , Li S , Jiang C , Wang S , Wang Z , Liu G , Hu S , |
|
|
Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 14 Pages: Pub: 2023 Jul 24 Epub: 2023 Jul 24 Authors de la Rubia Ortí JE , Moneti C , Serrano-Ballesteros P , Castellano G , Bayona-Babiloni R , Carriquí-Suárez AB , Motos-Muñoz M , Proaño B , Benlloch M , |
|
|
Tea polyphenol and epigallocatechin gallate ameliorate hyperlipidemia via regulating liver metabolism and remodeling gut microbiota. ✅
Go to Publication ✅
Food chemistry (Food Chem ) Vol: 404 Issue Pt A Pages: 134591 Pub: 2023 Mar 15 Epub: 2022 Oct 14 Authors Wen JJ , Li MZ , Chen CH , Hong T , Yang JR , Huang XJ , Geng F , Hu JL , Nie SP , |
|
|
Epigallocatechin-3-Gallate Decreases Plasma and Urinary Levels of p-Cresol by Modulating Gut Microbiota in Mice. ✅
Go to Publication ✅
ACS omega (ACS Omega ) Vol: 7 Issue 44 Pages: 40034-40041 Pub: 2022 Nov 8 Epub: 2022 Oct 28 Authors Unno T , Ichitani M , |
|
|
Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic db/db Mice: Lactobacillus Is a Putative Target. ✅
Go to Publication ✅
Journal of medicinal food (J Med Food ) Vol: 23 Issue 10 Pages: 1033-1042 Pub: 2020 Oct Epub: Authors Park JM , Shin Y , Kim SH , Jin M , Choi JJ , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
